ReportGem ReportGem

U.S. COMPANY FILING

Elevance Health, Inc. — Form 10-Q filed 2026-07-15

Filed: 2026-07-15Company: Elevance Health, Inc.Ticker: ELVExchange: NYSEForm: 10-QReport period: 2026-06-30SEC accession: 0001156039-26-000060Event: earningsMateriality: 75

Filing text preview

Elevance Health reported Q2 2026 revenue of $50.47B, up 1.4% YoY, and net income of $1.45B, down 16.6%. H1 revenue was $100.66B, net income $3.21B. The company initiated a 2026-2027 Operating Model Transformation Program, incurring costs. It also accrued for a Medicare Advantage risk adjustment data resubmission contingency and paid CMS $342M.

This preview uses text already stored in ReportGem and does not fetch the document from object storage during SEO generation. Review the internal filing record and the official SEC source before relying on it.

Open filing record